Improved Dengue Virus Plaque Formation on BHK21 and LLCMK 2
|
|
- Theodore Stone
- 6 years ago
- Views:
Transcription
1 Improved Dengue Virus Plaque Formation on BHK21 and LLCMK 2 Cells: Evaluation of Some Factors Mayling Alvarez, Rosmari Rodriguez-Roche, Lídice Bernardo, Luis Morier and Maria G. Guzman! Department of Virology, PAHO/WHO Collaborating Center for Viral Diseases, "Pedro Kourí" Tropical Medicine Institute, Havana, Cuba Abstract Neutralizing antibodies play a key role in the prevention of dengue infection. It is important that dengue virus plaque titration and plaque reduction neutralization tests (PRNT) be highly reproducible using standardized methods. To evaluate factors that have influence in the PRNT for dengue viruses, neutralizing antibodies were determined in 24 serum samples and 12 blood samples collected on filter paper, obtained through national dengue surveillance in Cuba. The influence of ph in the overlay medium, the percentage of ambient CO 2, the use of two different cell lines and of rapid centrifugation on dengue plaque formation were evaluated. The efficiency of the plaquing system was optimal when the overlay medium was buffered to ph 7.5. The rapid centrifugation of the virus on confluent cells increased the virus titres. Higher virus titres were obtained on BHK21 rather than LLCMK 2 cells when the viruses were added to cell suspension. Under optimal conditions, PRNT was highly reproducible and is recommended for seroepidemiological and vaccine studies using either BHK21 or LLCMK 2 cells. This communication also highlights the infection of LLCMK 2 cell suspensions for measuring neutralizing antibodies. Keywords: Dengue, plaque reduction neutralization technique, diagnosis, Cuba. Introduction Dengue fever (DF)/dengue haemorrhagic fever (DHF) has re-emerged as a public health problem worldwide [1-3]. The dengue viruses are serologically classified into four antigenically distinct serotypes (DENV-1, DENV-2, DENV-3 and DENV-4) and are maintained in a humanmosquito transmission cycle, with Aedes aegypti as the main vector. Currently, dengue is endemic in most of the tropical areas in the world [4,5]. Despite the antigenic relatedness of dengue viruses, two or more serotypes may sequentially infect one host. Epidemiological studies in Thailand and Cuba showed that DHF occurs in individuals with a secondary infection. These studies suggest that the presence of heterotypic dengue antibodies in a sequential secondary infection is a risk factor for developing the severe disease [6,7]. Neutralizing antibodies to dengue virus play a very significant role in the prevention of dengue! lupe@ipk.sld.cu; " ; Fax: Dengue Bulletin Vol 29,
2 infection. Non-neutralizing cross-reactive antibodies augment dengue virus infection of Fc receptor cells. These virus antibody complexes bind to Fc receptors on cells via the Fc portion of IgG, resulting in enhancement of dengue virus infection. This phenomenon has been called antibody-dependent enhancement (ADE) [8,9]. The ideal vaccine against DF and DHF must prevent infection caused by all serotypes avoiding ADE. Ideally, life-long neutralizing antibodies to the four serotypes should be present [10,11]. Towards this end, technological innovation for improved plaque formation such as speed, accuracy, economy, ease of performing test as well as global standardization is urgently required. Plaque reduction neutralization technique (PRNT) remains the gold standard for the titration of neutralizing antibodies. Several protocols have been described; however, factors affecting the reproducibility of dengue plaque assays have not been fully studied [12-21]. These include the use of solid or semi-sold substances in overlay media, the cell substrate, serum inhibitors and ph of the overlay medium. Taking into account the need to determine neutralizing antibodies for seroepidemiological and vaccine studies, we decided to validate a reliable plaque assay system to the four dengue serotypes. The influence of ph range in the overlay medium and the percentage of CO 2 atmosphere for cell incubation were evaluated. Also, the usefulness of rapid centrifugation (shell vial assay) to improve the efficiency of virus adsorption and consequently plaque formation was also evaluated. Finally, efficiency for virus titration and PRNT of baby hamster kidney cell line (BHK21) and LLCMK 2 as cell suspensions were compared. Materials and Methods Viruses Table 1 shows the dengue virus strains used in this study. Serum specimens A total of 24 sera obtained through the Cuban national dengue surveillance system during Table 1. Details of the strains utilized in the neutralization tests P: passage, MB: mouse brain, M: mosquitoes 50 Dengue Bulletin Vol 29, 2005
3 2000 and 12 blood samples collected on filter paper from healthy individuals during 2003 were selected for study. The first samples were used to test the reproducibility of PRNT on BHK21 cells. Filter paper eluates were tested for DENV-1 to DENV-4 neutralizing antibodies on BHK21 and LLCMK 2 cells at a 1:30 dilution, using exactly the same methods used previously [22]. Antibody titres obtained in both cells were compared. Cell culture BHK21, clone 15 cells were grown at 37 C in complete medium E-MEM (Minimum Essential Medium with Earle s balance salts) supplemented with 10% of heat-inactivated foetal bovine serum, 1% penicillin/ streptomycin, 10% L-glutamine and sodium bicarbonate for adjusting the medium to ph LLCMK 2 cells (ATCC) were kindly provided by Sutee Yoksan (Center for Vaccine Development, Mahidol University) and were grown in the same conditions. Virus titration Plaque titration was performed on BHK21, clone 15 and in LLCMK 2 as previously described by Morens et al [16]. For virus titration, 50 ul of virus dilutions (10 1 to 10 6 ) was added to 0.5 ml of BHK21 cell suspension (1.5 x 10 5 cells) in each of three wells of a 24-well polystyrene plate. After 4 hours incubation at 37 C in CO 2 atmosphere, each well received 0.5 ml of 3% medium viscosity carboxymethyl cellulose made up in Earle s minimum essential medium without phenol red (MEM) with 10% heat-inactivated foetal bovine serum, 1% glutamine 2 mm and 100 U of penicillin plus 100 ug/ml streptomycin. Infected cells were incubated for 5 9 days in the same conditions as above depending on the virus serotype (7 9 days for DENV-1 and DENV-3, 5 days for DENV-2 and 6 days for DENV-4) in the case of BHK21, and for the LLCMK 2 cells the plaques of all the serotypes were counted on the 7 th day. After incubation, plates were rinsed gently under tap water and fixed and stained with a solution of naphthol blue black and acetic acid [16]. Plaque Reduction Neutralization Test (PRNT) PRNT was performed on both tested cell lines. For antibody titration, 100 ul of serum dilution (in MEM) was incubated for 1 hour at 37 C with 100 ul of the virus working dilution calculated to give pfu/50 ul of the final volume of virus-serum mixture. After incubation, 50 ul of virus-serum mixture was added to the cell suspension in triplicate. The ph during the virus adsorption was in the range Plates were incubated for 4 hours at 37 C under CO 2 atmosphere. The rest was followed as above. Each serum dilution was tested four times. Calculations of 50% endpoint plaque reduction neutralization titres were made using log probit paper by the method of Russell et al., 1967 [23]. Evaluation of ph of overlay medium, CO 2 atmosphere and rapid centrifugation of virus during cell adsorption phase on the efficiency of dengue virus plaque assays in BHK21 cells (1) In order to evaluate the influence of the ph of the nutrient overlay medium, this was adjusted at 6.5, 7, 7.5 and 8 final ph using a solution of 7.5% sodium bicarbonate. Cells were incubated under CO 2 atmosphere at 4% and the four dengue serotypes were titrated. (2) To test the influence of CO 2 atmosphere, the ph of the overlay medium was adjusted to 7.5, and cells were incubated Dengue Bulletin Vol 29,
4 under CO 2 atmosphere both at 4 and 4.5%. Under these conditions the four dengue serotypes were titrated. (3) For the evaluation of the rapid centrifugation assay, 24 well plates were used. DENV-2/A15 strain was inoculated on cells in suspension or monolayer and centrifuged at x G (1500 rpm) for 30 min at 37 C using an ALC model PM 140/140R centrifuge. After centrifugation, cells were incubated for 4 hours at 37 C and overlay media (at ph 7.5) was added. Infected cells were incubated at 37 C in CO 2 atmosphere at either 4 or 4.5%. Results Evaluation of different factors influencing dengue virus plaque assays in BHK21 cells Effect of ph of overlay medium Titres of DENV-1, 3 and 4 depended on ph of overlay media (Table 2). The highest titres were observed at ph 7.5. For DENV-2, titres were relatively similar at ph values ranging from 6.5 to 7.5, ph 7.5 being the optimal. Table 2. Effect of ph of overlay medium on dengue viruses plaque formation NP: no plaques Influence of CO 2 atmosphere Considering that the highest titres of the four dengue serotypes were observed at ph 7.5 of the overlay medium, this ph was used to test the influence of CO 2 atmosphere. In general, titre and plaque size were relatively unaffected by cell incubation under 4 or 4.5% CO 2 atmosphere. Influence of rapid centrifugation of virus during cell adsorption phase Table 3 shows the effect of dengue virus plaque formation of rapid centrifugation assay both in cell suspensions and confluent monolayer. Rapid centrifugation on confluent cell cultures gave the highest viral titres, compared to the conventional method, both at 4 and 4.5% of CO 2 atmosphere. Table 3. Effect on dengue virus plaque formation of rapid centrifugation assay using cell suspensions and confluent monolayer at two different percentages of CO 2 atmosphere* * ph of overlay medium was adjusted to Dengue Bulletin Vol 29, 2005
5 Table 4. Replicate 50% neutralizing antibody titres and geometric mean titres (GMT) to DENV-1 and DENV-2 on BHK21 cells *Each serum was tested twice at two different days. Results are presented here as number 1 to 4. Dengue Bulletin Vol 29,
6 Reproducibility of dengue PRNT assays in BHK21 To test the reproducibility of PRNT assays, sera were tested twice on two different days (in total, antibody titre in each serum was determined four times). Titres less than 1/10 to DENV-3 and -4 were obtained. Only 2 (8.3%) sera showed greater than twofold differences in the neutralizing antibody titre to DENV-1 (Table 4). Comparison of BHK21 and LLCMK 2 cells for virus titration and assay of neutralizing antibody Titres of the four dengue viruses on BHK21 and LLCMK 2 cell lines using an overlay media buffered to ph 7.5 and incubated at 37 C in a 4% CO 2 atmosphere were compared. With the exception of DENV-3, the highest viral titres were obtained on BHK21 cell cultures (Table 5). Viral plaques were similar in size and morphology in both cell lines with the exception of DENV-4 plaques that were larger in both cultures. Table 5. DENV-1 to -4 titres determined by plaque assay on BHK21 and LLCMK 2 cell suspensions* *Plaque titre (Log 10 pfu/ml) The percentage of plaque reduction to each serotype was determined in 12 samples collected on filter papers tested in both cell lines. The results were similar in 100% of the samples (Table 6). Discussion Taking into account the necessity of measuring neutralizing antibodies during vaccine trials, it is important to apply standardized and validated methods. However, factors affecting the reproducibility of dengue plaque assays have not been fully identified. Of the factors studied in this work, the ph of the overlay medium was the most critical variable. The optimal ph of the overlay medium for obtaining clear dengue virus plaques was ph 7.5. Other investigators have reported optimal dengue virus plaquing over a wide range of ph values in the overlay medium (ph 6.6 to 8.6) when using LLCMK 2 cells [19]. When DENV-3 was assayed, plaque size decreased at ph 8.6 [19]. Dieg and Watkins [24] have found that Colorado tick fever virus plaque production was relatively insensitive over a range of ph of 7.1 to 8.1 while plaque formation failed to occur at ph 7.0 or lower. In hamster lung cell, plaque formation of Japanese encephalitis virus was not observed when ph of the overlay medium was under 6.6 or above 7.8. [18] Lee et al [25]. have reported dengue plaque formation at a ph range of 7.4 to 7.6. Sodium bicarbonate concentrations have been reported to influence plaque size with differences two- to eight-fold differences, especially for DENV-2, -3 and -4 [19]. In our study no significant difference in the plaque size was observed over the range of ph values tested, with the exception of DENV-4 which produced large plaques at ph 7.5. In general, titre and plaque size were relatively unaffected by incubating infected cells at different percentages of CO 2 atmosphere. Stim TB [19] have reported increased sensitivity of dengue virus plaque assays at high concentrations of sodium bicarbonate. 54 Dengue Bulletin Vol 29, 2005
7 Table 6. Comparative plaque reduction neutralization of DENV-1 to -4 in BHK21 and LLCMK 2 cells infected as cell suspension* *Whole blood on filter papers was re-suspended at 1:30 dilution In our laboratory, the rapid centrifugation or shell vial assay has greatly improved the isolation rate of some viruses. This method of enhancing virus-cell interactions decreases the time of the onset of cytopathic effect of many viruses present in clinical diagnostic specimens. It was applied to plaque assays and improved consistency of input virus dose. For dengue viruses, rapid centrifugation improved the isolation rate in blood and tissues [26]. Recently, Chingsuwanrote et al. (2004) observed a relationship of the number of plaques and postinfection incubation time, with the longest postinfection incubation time giving the highest number of plaques [27]. Dengue Bulletin Vol 29,
8 Several cell lines have been used for dengue plaque assays but there are few published comparisons between cell systems using optimized conditions [12,14,15,17,27]. In the present study, virus titres were higher in BHK21 than in LLCMK 2 cell cultures, except for DENV-3. In summary, (i) the ph of the overlay medium may be an important factor in obtaining clear and large dengue plaques; (ii) the centrifugation of virus inoculate on cells increases virus titres; (iii) higher virus titres were obtained in BHK21 compared with LLCMK 2 cell cultures; (iv) highly reproducible dengue PRNT titres were obtained on BHK21 cells; and (v) using the cell suspension method, DENV-3 resulted in higher titres in LLCMK 2 than BHK21 cells. The current work confirms that under optimal conditions, plaque reduction neutralization titres can be repeated reproducibly. Seroepidemiological and vaccine studies can be performed satisfactorily in both BHK21 and LLCMK 2 cells. Acknowledgements This work was supported by TDR/WHO grant ID No We thank Prof. Robert Shope of Texas University and Prof. Scott Halstead from the Pediatric Dengue Vaccine Initiative, Bethesda, Maryland, USA, for their useful suggestions and comments. References [1] Guzman MG and Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol. 2003; 27(1): [2] Guzman M, Kouri G, Diaz M, Llop A, Vazquez S, Gonzalez D, Castro O, Alvarez A, Fuentes O, Montada D, Padmanabha H, Sierra B, Perez A, Rosario D, Pupo M, Diaz C and Sanchez L. Dengue, one of the great emerging health challenges of the 21 st century. Expert Rev Vaccines. 2004; 3(5): [3] Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21 st century. Trends Microbiol. 2002; 10(2): [4] Gubler DJ. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev. 1998; 11(3): [5] Guzman MG and Kouri G. Dengue: an update. Lancet Infect Dis. 2002; 2(1): [6] Guzman MG, Kouri G, Valdes L, Bravo J, Alvarez M, Vazques S, Delgado I and Halstead SB. Epidemiologic studies on dengue in Santiago de Cuba, Am J Epidemiol. 2000; 152(9): [7] Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, Salitul V, Phanthumachinda B and Halstead SB. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol. 1984; 120(5): [8] Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science. 1988; 239(4839): [9] Halstead S. The pathogenesis of dengue. Molecular epidemiology in infectious disease. Am J Epidemiol. 1981; 114: [10] Halstead SB and Deen J. The future of dengue vaccines. Lancet. 2002; 360(9341): [11] Monath TP, McCarthy K, Bedford P, Johnson CT, Nichols R, Yoksan S, Marchesani R, Knauber M, Wells KH, Arroyo J and Guirakhoo F. Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections. Vaccine. 2002; 20(7-8): [12] Georgiades J, Stim TB, McCollum RW and Henderson JR. Dengue virus plaque formation in Rhesus monkey kidney cultures. Proc Soc Exp Biol Med. 1965; 118: [13] Guzman MG and Kouri G. Advances in dengue diagnosis. Clin Diagn Lab Immunol. 1996; 3(6): [14] Hotta S, Fujita N and Maruyama T. Research on dengue in tissue culture. I. Plaque formation in an 56 Dengue Bulletin Vol 29, 2005
9 established monkey kidney cell line culture. Kobe J Med Sci. 1966; 12(3): [15] Morens DM, Halstead SB and Larsen LK. Comparison of dengue virus plaque reduction neutralization by macro and semi-micro methods in LLC-MK2 cells. Microbiol Immunol. 1985; 29(12): [16] Morens DM, Halstead SB, Repik PM, Putvatana R and Raybourne N. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol. 1985; 22(2): [17] Rao BL. Plaque formation of dengue viruses in Vero cell culture under carboxy-methylcellulose overlay. Indian J Med Res. 1976; 64(12): [18] Schulze IT and Schlesinger RW. Plaque assay of dengue and other group B arthropod-borne viruses under methyl cellulose overlay media. Virology. 1963; 19: [19] Stim TB. Dengue virus plaque development in simian cell systems. I. Factors influencing virus adsorption and variables in the agar overlay medium. Appl Microbiol. 1970; 19(5): [20] Stim TB. Dengue virus plaque development in simian cell systems. II. Agar variables and effect of chemical additives. Appl Microbiol. 1970; 19(5): 757. [21] Yuill TM, Sukhavachana P, Nisalak A and Russell PK. Dengue-virus recovery by direct and delayed plaques in LLC-MK2 cells. Am J Trop Med Hyg. 1968; 17(3): [22] Bravo JR, Guzman MG and Kouri GP. Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans R Soc Trop Med Hyg. 1987; 81(5): [23] Russell PK, Nisalak A, Sukhavachana P and Vivona S. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol. 1967; 99(2): [24] Dieg EF and Watkins HMS. Plaque assay procedure for Colorado tick fever virus. J Bacteriol. 1964; 88: [25] Lee GC-Y, Grayston T and Kenney G. Growth of Japanese encephalitis virus in cell cultures. J Infect Dis. 1955; 115: [26] Rodriguez-Roche R, Alvarez M, Guzman MG, Morier L and Kouri G. Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells. J Clin Microbiol. 2000; 38(9): [27] Chingsuwanrote P, Suksanpaisan L and Smith DR. Adaptation of the plaque assay methodology for dengue virus infected HepG2 cells. J Virol Methods. 2004; 116(2): Dengue Bulletin Vol 29,
Effects of Cell Culture and Laboratory Conditions on Type 2 Dengue Virus Infectivity
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1979, p. 235-239 0095-1137/79/08-0235/05$02.00/0 Vol. 10, No. 2 Effects of Cell Culture and Laboratory Conditions on Type 2 Dengue Virus Infectivity JARUE S. MANNING*
More informationprovided the original work is prope
NAOSITE: Nagasaki University's Ac Title Author(s) Persistence of Neutralizing Antibod Years from Infection in Nagasaki Ngwe Tun, Mya Myat; Muta, Yoshihito Citation BioResearch Open Access, 5(1), pp.1 Issue
More informationViruses. The following Caribbean strains of dengue viruses
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1985, p. 250-254 0095-1137/85/080250-05$02.00/0 Copyright C 1985, American Society for Microbiology Vol. 22, No. 2 Simplified Plaque Reduction Neutralization Assay
More informationENZYME-LINKED IMMUNOSORBENT ASSAY-FORMAT MICRONEUTRALIZATION TEST FOR DENGUE VIRUSES
Am. J. Trop. Med. Hyg., 66(2), 2002, pp. 208 212 ENZYME-LINKED IMMUNOSORBENT ASSAY-FORMAT MICRONEUTRALIZATION TEST FOR DENGUE VIRUSES VANCE VORNDAM AND MANUELA BELTRAN Dengue Branch, Division of Vector-Borne
More informationDengue Haemorrhagic Fever in Thailand, : Primary or Secondary Infection
Dengue Haemorrhagic Fever in Thailand, 1998-2003: Primary or Secondary Infection by M Sriprom*, P Pongsumpun*, S Yoksan**, P Barbazan***, J P Gonzalez** and I M Tang +# *Department of Mathematics, Faculty
More informationReceived 26 September 2009/Returned for modification 29 October 2009/Accepted 18 December 2009
CLINICAL AND VACCINE IMMUNOLOGY, Mar. 2010, p. 402 407 Vol. 17, No. 3 1556-6811/10/$12.00 doi:10.1128/cvi.00396-09 Copyright 2010, American Society for Microbiology. All Rights Reserved. Discrepancy in
More informationIncreased IL-10 levels during dengue virus infection. Dr. Ana B. Perez Dept. Virology Institute for Tropical Medicine Pedro Kouri Cuba
Increased IL-10 levels during dengue virus infection Dr. Ana B. Perez Dept. Virology Institute for Tropical Medicine Pedro Kouri Cuba IPK Dengue virus infections: Spectrum of an illness Asymptomatic Dengue
More informationELISA as an alternative tool for epidemiological surveillance for dengue in mosquitoes: a report from Thailand
J Vector Borne Dis 44, December 2007, pp. 272 276 ELISA as an alternative tool for epidemiological surveillance for dengue in mosquitoes: a report from Thailand Mayuna Srisuphanunt a, Ratana Sithiprasasna
More informationRole of Interferon in the Propagation of MM Virus in L Cells
APPLIED MICROBIOLOGY, Oct. 1969, p. 584-588 Copyright ( 1969 American Society for Microbiology Vol. 18, No. 4 Printed in U S A. Role of Interferon in the Propagation of MM Virus in L Cells DAVID J. GIRON
More informationImmune protection against dengue infection. Vaccine performance
Immune protection against dengue infection. Vaccine performance SCOTT B HALSTEAD MD Department of Preventive Medicine Uniformed Services University of the Health Sciences TOPICS Current dengue vaccines:
More informationDengue IgG/IgM/NS1 Combo Rapid Test Device
Dengue IgG/IgM/NS1 Combo Rapid Test Device Cat.No: DTSXY-L2 Lot. No. (See product label) Intended Use The Dengue IgG/IgM/NS1 Combo Rapid Test Device is a lateral flow chromatographic immunoassay for the
More informationDIAGNOSIS OF DENGUE INFECTION USING VARIOUS DIAGNOSTIC TESTS IN THE EARLY STAGE OF ILLNESS
DIAGNOSIS OF DENGUE INFECTION USING VARIOUS DIAGNOSTIC TESTS IN THE EARLY STAGE OF ILLNESS Rangsima Lolekha 1, Kulkanya Chokephaibulkit 1, Sutee Yoksan 2, Nirun Vanprapar 1, Wanatpreeya Phongsamart 1 and
More informationJapanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy
Available online at www.sciencedirect.com Vaccine 25 (2007) 8257 8261 Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy Thanyawee
More informationEVALUATION OF THE EFFECTIVENESS OF A 7% ACCELERATED HYDROGEN PEROXIDE-BASED FORMULATION AGAINST CANINE PARVOVIRUS
Final report submitted to Virox Technologies, Inc. EVALUATION OF THE EFFECTIVENESS OF A 7% ACCELERATED HYDROGEN PEROXIDE-BASED FORMULATION AGAINST CANINE PARVOVIRUS Syed A. Sattar, M.Sc., Dip. Bact., M.S.,
More informationDengue-2 Vaccine: Viremia and Immune Responses in Rhesus Monkeys
INFECTION AND IMMUNITY, Jan. 1980, p. 181-186 0019-9567/80/01-0181/06$02.00/0 Vol. 27, No. 1 Dengue-2 Vaccine: Viremia and Immune Responses in Rhesus Monkeys ROBERT McN. SCOTT,'t* ANANDA NISALAK,' KENNETH
More informationA. Study Purpose and Rationale
IRB Proposal/CRC Rotation Sabrina J Gard, MD MPH Internal Medicine, PGY 1 5 May 2014 A. Study Purpose and Rationale Dengue is the most prevalent arthropod-transmitted virus, with conservative estimates
More informationQuantitative Assay of Paravaccinia Virus Based
APPrU MICROBIOLOGY, JUly 1972, p. 138-142 Copyright 1972 American Society for Microbiology Vol. 24, No. 1 Printed in U.S.A. Quantitative Assay of Paravaccinia Virus Based on Enumeration of Inclusion-Containing
More informationDIAGNOSTICS ALGORITHMS IN DENGUE INFECTIONS
ECDC training Workshop on laboratory diagnosis of dengue virus infections Berlin, 23 27 January 2012 DIAGNOSTICS ALGORITHMS IN DENGUE INFECTIONS Cristina Domingo Carrasco Robert Koch Institut KINETICS
More informationCellular Immunology 262 (2010) Contents lists available at ScienceDirect. Cellular Immunology
Cellular Immunology 262 (2010) 134 140 Contents lists available at ScienceDirect Cellular Immunology journal homepage: www.elsevier.com/locate/ycimm Secondary heterologous dengue infection risk: Disequilibrium
More informationSpatial and Temporal Circulation of Dengue Virus Serotypes: A Prospective Study of Primary School Children in Kamphaeng Phet, Thailand
American Journal of Epidemiology Copyright 2002 by the Johns Hopkins Bloomberg School of Public Health All rights reserved Vol. 156, No. 1 Printed in U.S.A. DOI: 10.1093/aje/kwf006 Spatial and Temporal
More informationIntroduction. Vincent T.K. Chow!, C.S. Lim, M.C. Phoon and H.C. Tan. Abstract
A Seroprevalence Survey of Dengue Virus Infection in Healthy Singapore University Undergraduates by Enzyme Immunoassay and Plaque Reduction Neutralization Test Vincent T.K. Chow!, C.S. Lim, M.C. Phoon
More informationANTIBODIES DETERMINE VIRULENCE IN DENGUE. Scott B HALSTEAD, M.D. DIRECTOR, Research Pediatric Dengue Vaccine Initiative IVI, Seoul, Korea
ANTIBODIES DETERMINE VIRULENCE IN DENGUE Scott B HALSTEAD, M.D. DIRECTOR, Research Pediatric Dengue Vaccine Initiative IVI, Seoul, Korea Global Spread of Dengue 50-100 million infections/year Countries
More informationLong-term Immunogenicity Following Vaccination with a New, Live-attenuated Vaccine Against Japanese Encephalitis (JE-CV)
Long-term Immunogenicity Following Vaccination with a New, Live-attenuated Vaccine Against Japanese Encephalitis (JE-CV) Sutee Yoksan, M.D., Ph.D. Center for Vaccine Development, Mahidol University Joint
More informationOlarn Prommalikit 1, Woraman Waidab 2, Kanya Suphapeetiporn 3 and Usa Thisyakorn 3
CYTOKINE-RELATED GENE EXPRESSION IN PERIPHERAL BLOOD LEUKOCYTES AND DENGUE INFECTION SEVERITY Olarn Prommalikit 1, Woraman Waidab 2, Kanya Suphapeetiporn 3 and Usa Thisyakorn 3 1 Department of Pediatrics,
More informationINTRABULBAR INOCULATION OF JAPANESE ENCEPHALITIS VIRUS TO MICE
THE KURUME MEDICAL JOURNAL Vol. 15, No. 1, 1968 INTRABULBAR INOCULATION OF JAPANESE ENCEPHALITIS VIRUS TO MICE TOSHINORI TSUCHIYA Department of Microbiology, and Department of Ophthalmology, Kurume University
More informationINTRODUCTION MATERIALS AND METHODS
Am. J. Trop. Med. Hyg., 69(2), 2003, pp. 129 134 Copyright 2003 by The American Society of Tropical Medicine and Hygiene INDUCTION OF NEUTRALIZING ANTIBODIES AND PARTIAL PROTECTION FROM VIRAL CHALLENGE
More informationProduction of Interferon Alpha by Dengue Virus-infected Human Monocytes
J. gen. Virol. (1988), 69, 445-449. Printed in Great Britain 445 Key words: IFN-ct/dengue virus/monocytes Production of Interferon Alpha by Dengue Virus-infected Human Monocytes By ICHIRO KURANE AND FRANCIS
More informationRetrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000
J Microbiol Immunol Infect. 2008;41:377-385 Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000 Shu-Fen Chang 1, Jyh-Hsiung Huang
More informationPrincipal Investigators ~ Ananda Nisalak, M.D. Donald s. Burke~ MAJ~ MC Douglas M. Watts, Ph.D.
Effect of Intravenous Inoculation of Bordetella Pertussis Vaccine on the In vivo Viremia and Antibody Response to Flavi~Tirus Infection in Rhesus Monkeys Principal Investigators ~ Ananda Nisalak, M.D.
More informationVirus evolution during a severe dengue epidemic in Cuba, 1997 $
Virology 334 (2005) 154 159 Rapid Communication Virus evolution during a severe dengue epidemic in Cuba, 1997 $ Rosmari Rodriguez-Roche a, Mayling Alvarez a, Tamara Gritsun b, Scott Halstead c, Gustavo
More informationDengue Infection at Children's Hospital of Bangkok
Dengue Infection at Children's Hospital of Bangkok Principal Investigators : Robert McNair Scott, MAJ, MC Suchitra Nimmannitya, M.D.1 Pethai Mansuwan, M.D.1 Franklin H. Top, Jr., LTC, MC William H. Bancroft,
More informationRESEARCH NOTE IDENTIFICATION OF DENGUE VIRUS IN AEDES MOSQUITOES AND PATIENTS SERA FROM SI SA KET PROVINCE, THAILAND
RESEARCH NOTE IDENTIFICATION OF DENGUE VIRUS IN AEDES MOSQUITOES AND PATIENTS SERA FROM SI SA KET PROVINCE, THAILAND Chai Teerasut 1, Udom Petphuwadee 1, Suwich Thammapalo 2, Wipawee Jampangern 3 and Kriengsak
More informationSOME PROPERTIES OF ECHO AND COXSACKIE VIRUSES IN TISSUE CULTURE AND VARIATIONS BY HEAT
THE KURUME MEDICAL JOURNAL Vol. 9, No. 1, 1962 SOME PROPERTIES OF ECHO AND COXSACKIE VIRUSES IN TISSUE CULTURE AND VARIATIONS BY HEAT SHIGERU YAMAMATO AND MASAHISA SHINGU Department of Microbiology, Kurume
More informationProtection of Rhesus Monkeys against Dengue Virus Challenge after Tetravalent Live Attenuated Dengue Virus Vaccination
MAJOR ARTICLE Protection of Rhesus Monkeys against Dengue Virus Challenge after Tetravalent Live Attenuated Dengue Virus Vaccination Wellington Sun, 1 Ananda Nisalak, 3 Montip Gettayacamin, 4 Kenneth H.
More informationPre-clinical Development of a Dengue Vaccine. Jeremy Brett Sanofi Pasteur, Singapore
Pre-clinical Development of a Dengue Vaccine Jeremy Brett Sanofi Pasteur, Singapore Dengue Vaccine B Guy 1 Talk flow Introduction: What are the challenges of dengue vaccine development? The Virus The host
More informationMODULE 5. Dengue. Edwin J. Asturias Associate Professor of Pediatrics Senior Investigator Director for Latin America
MODULE 5 Dengue Edwin J. Asturias Associate Professor of Pediatrics Senior Investigator Director for Latin America Symptoms of Dengue Fever Dengue: Skin rashes DHF manifestations Hemorrhages Thrombocytopenia
More informationReceived 16 August 2001/Returned for modification 20 October 2001/Accepted 17 February 2002
JOURNAL OF CLINICAL MICROBIOLOGY, May 2002, p. 1840 1844 Vol. 40, No. 5 0095-1137/02/$04.00 0 DOI: 10.1128/JCM.40.5.1840 1844.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.
More informationEvaluation of Some Clinical, Humoral and Imagenological Parameters in Patients of Dengue Haemorrhagic Fever Six Months after Acute Illness
Evaluation of Some Clinical, Humoral and Imagenological Parameters in Patients of Dengue Haemorrhagic Fever Six Months after Acute Illness Daniel González*, Raiza Martínez**, Osvaldo Castro*, Teresita
More informationPathogenesis of Simian Foamy Virus Infection in Natural and Experimental Hosts
INCTION AD ImmuNrry, Sept. 1975, p. 470-474 Copyright 0 1975 American Society for Microbiology Vol. 12, No. 3 Printed in U.S.A. Pathogenesis of Simian Foamy Virus Infection in Natural and Experimental
More informationSeroprevalence and Recent Trends of Dengue in a Rural Area in South India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 1 (2017) pp. 36-41 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2017.601.005
More informationNOTES CONTAMINATION OF CYNOMOLGUS MONKEY KIDNEY CELL CULTURES BY HEMAGGLUTINATING SIMIAN VIRUS (SV 5)
Japan. J. Med. Sci. Biol., 18, 151-156, 1965 NOTES CONTAMINATION OF CYNOMOLGUS MONKEY KIDNEY CELL CULTURES BY HEMAGGLUTINATING SIMIAN VIRUS (SV 5) Since the extensive use of cynomolgus monkey kidney cell
More informationHuman Immunoglobulin Specificity After Group B Arbovirus Infections
INFECTION AND IMMUNITY, Sept. 97, p. 77- Copyright @ 97 American Society for Microbiology Vol. 6, No. 3 Printed in U.S.A. Human Immunoglobulin Specificity After Group B Arbovirus Infections ROBERT McNAIR
More informationShort Communication. Pathological Features of Heterologous Immunity Are Regulated by the Private Specificities of the Immune Repertoire
The American Journal of Pathology, Vol. 176, No. 5, May 2010 Copyright American Society for Investigative Pathology DOI: 10.2353/ajpath.2010.090656 Short Communication Pathological Features of Heterologous
More informationBy NATHALIE J. SCHMIDT, E. H. LENNETTE AND R. L. MAGOFFIN
J. gen. ViroL 0969), 4, 321-328 Printed in Great Britain 32I Immunological Relationship between Herpes Simplex and Varicella-zoster Viruses Demonstrated by Complement-fixation, Neutralization and Fluorescent
More informationIntroduction. Abstract
Comparison between Haemagglutination Inhibition (HI) Test and IgM and IgG-capture ELISA in Determination of Primary and Secondary Dengue Virus Infections Atchareeya A-nuegoonpipat a, Songthum Prakong a,
More informationDengue Vaccine Butantan Institute. DCVMN, Bangkok, 2015
Dengue Vaccine Butantan Institute DCVMN, Bangkok, 2015 GENOME Dengue Viruses Dengue is a mosquito-borne RNA virus with 4 distinct serotypes: 1,2,3,and 4 3 structural proteins: C, prm, and E E protein is
More informationGlobal Perspectives on Dengue Research
By Scott B. Halstead Adjunct Professor, Department of Preventive Medicine, Uniformed Services, University of the Health Sciences, Bethesda, MD, USA Abstract Dengue viruses infect nearly 100 million human
More informationSOEDARTO SOEKIMAN*, EIJI KONISHI AND TAKEO MATSUMURA Received October /Accepted January
Japan. J. Trop. Med. Hyg., Vol. 15, No. 1, 1987, pp. 37-41 Short Communication A COMPARATIVE STUDY ON GROWTH OF DENGUE TYPE 3 AND CHIKUNGUNYA VIRUSES IN INDONESIAN COLONIES OF AEDES AEGYPTI AND AEDES ALBOPICTUS
More informationHost for Dengue Viruses
Evaluation of Toxorhynahites splendens (Diptera: Culicidae) as a Bioassay Host for Dengue Viruses Principal Investigators:: Douglas M. Watts.~ Ph.D. Bruce A. Harrison, MAJ, MSC Ananda Nisalak, M.D. Donald
More informationANTIGEN SANDWICH ELISA PREDICTS RT-PCR DETECTION OF DENGUE VIRUS GENOME IN INFECTED CULTURE FLUIDS OF AEDES ALBOPICTUS C6/36 CELLS
ANTIGEN SANDWICH ELISA PREDICTS RT-PCR DETECTION OF DENGUE VIRUS GENOME IN INFECTED CULTURE FLUIDS OF AEDES ALBOPICTUS C6/36 CELLS Corazon C Buerano 1,2, Filipinas F Natividad 2, Rodolfo C Contreras 3,
More informationSEROLOGICAL DIAGNOSIS OF DENGUE INFECTIONS
ECDC training Workshop on laboratory diagnosis of dengue virus infections Berlin, 23 27 January 2012 SEROLOGICAL DIAGNOSIS OF DENGUE INFECTIONS Cristina Domingo Carrasco Robert Koch Institut FACILITIES
More informationDengue-2 Vaccine: Preparation from a Small-Plaque Virus Clone
INFECTION AND IMMUNITY, Jan. 1980, p. 175-180 0019-9567/80/01-0175/06$02.00/0 Vol. 27, No. 1 Dengue-2 Vaccine: Preparation from a Small-Plaque Virus Clone KENNETH H. ECKELS,* VENTON R. HARRISON, PETER
More informationRELATIONSHIP BETWEEN BODY SIZE AND SEVERITY OF DENGUE HEMORRHAGIC FEVER AMONG CHILDREN AGED 0-14 YEARS
BODY SIZE AND SEVERITY OF DHF AMONG CHILDREN RELATIONSHIP BETWEEN BODY SIZE AND SEVERITY OF DENGUE HEMORRHAGIC FEVER AMONG CHILDREN AGED 0-14 YEARS Natchaporn Pichainarong 1, Noparat Mongkalangoon 2, Siripen
More informationPERSISTENT INFECTIONS WITH HUMAN PARAINFLUENZAVIRUS TYPE 3 IN TWO CELL LINES
71 PERSISTENT INFECTIONS WITH HUMAN PARAINFLUENZAVIRUS TYPE 3 IN TWO CELL LINES Harold G. Jensen, Alan J. Parkinson, and L. Vernon Scott* Department of Microbiology & Immunology, University of Oklahoma
More informationGamma Interferon Augments FcY Receptor-Mediated Dengue
JOURNAL OF VIROLOGY, Nov. 1988, p. 3928-3933 0022-538X/881113928-06$02.00/0 Copyright 1988, American Society for Microbiology Vol. 62, No. 11 Gamma Interferon Augments FcY Receptor-Mediated Dengue Virus
More informationThe Features of Imported Dengue Fever Cases Confirmed at National Institute of Infectious Diseases Japan, during p
The Features of Imported Dengue Fever Cases Confirmed at National Institute of Infectious Diseases Japan, during 2001 +p by Ken-Ichiro Yamada* #, Tomohiko Takasaki*, Masaru Nawa**, Reiko Nerome*, Yohko
More informationPublic Health Image Library. CDC/ Cynthia Goldsmith. Image #
Zika Virus Fredrick M. Abrahamian, D.O., FACEP, FIDSA Clinical Professor of Medicine UCLA School of Medicine Director of Education Department of Emergency Medicine Olive View-UCLA Medical Center Sylmar,
More informationIn Vitro Cultivation of Human Rotavirus in MA 104 Cells
Acute Diarrhea: Its Nutritional Consequences in Children, edited by J. A. Bellanti. Nestle, Vevey/Raven Press, New York 1983. ETIOLOGIC AGENTS OF ACUTE DIARRHEA In Vitro Cultivation of Human Rotavirus
More informationUsa Thisyakorn and Chule Thisyakorn
CHILDHOOD DENGUE DISEASES: A TWENTY YEARS PROSPECTIVE STUDY Usa Thisyakorn and Chule Thisyakorn Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Abstract. Dengue
More informationSequential dengue virus infections detected in active and passive surveillance programs in Thailand,
Bhoomiboonchoo et al. BMC Public Health (2015) 15:250 DOI 10.1186/s12889-015-1590-z RESEARCH ARTICLE Open Access Sequential dengue virus infections detected in active and passive surveillance programs
More informationPlaque Assay of Sendai Virus in Monolayers of a Clonal Line
JOURNAL OF CUNICAL MICROBIOLOGY, Feb. 1976. p. 91-95 Copyright 1976 American Society for Microbiology Vol. 3, No. 2 Printed in U.SA. Plaque Assay of Sendai Virus in Monolayers of a Clonal Line of Porcine
More informationYellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D
AppuzD MmcoaioLOGy, Apr. 1973, p. 539-544. Copyright i 1973 American Society for Microbiology Vol. 25, No. 4 Printed in U.SA. Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D
More informationMaking Dengue a Vaccine Preventable Disease
Making Dengue a Vaccine Preventable Disease Harold S. Margolis, MD, FAAP Joint International Tropical Medicine Meeting (JITMM) Bangkok, Thailand October 13, 2008 Dengue Vaccines Where are We Today? No
More informationInhibition of Dengue Virus Replication by Amantadine Hydrochloride
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, JUly 1980, p. 125-129 0066-4804/80/07-0125/05$02.00/0 Vol. 18, No. 1 Inhibition of Dengue Virus Replication by Amantadine Hydrochloride WAYNE C. KOFF,* JOE L. ELM,
More informationNorovirus Report. Can copper and silver ionisation kill norovirus? A Study Report
Norovirus Report Can copper and silver ionisation kill norovirus? A Study Report Can copper and silver ionisation kill norovirus? A Study Report Introduction Norovirus is the leading cause of non-bacterial
More informationFlavivirus Vaccines Japanese Encephalitis and Dengue
Flavivirus Vaccines Japanese Encephalitis and Dengue 14 th Advanced Vaccinology Course Veyrier du Lac, France May 16, 2012 Harold S. Margolis, MD Dengue Branch Centers for Disease Control and Prevention
More informationCurrent Status of Dengue Diagnosis at the Center for Disease Control, Taiwan
Current Status of Dengue Diagnosis at the Center for Disease Control, Taiwan Pei-Yun Shu, Shu-Fen Chang, Yi-Yun Yueh, Ling Chow, Li-Jung Chien, Yu-Chung Kuo, Chien-Lin Su, Tsai-Ling Liao, Ting-Hsiang Lin
More informationEffect of Complement and Viral Filtration on the
APPLIED MICROBIOLOGY, JUlY 1968, p. 1076-1080 Copyright @ 1968 American Society for Microbiology Vol. 16, No. 7 Printed in U.S.A. Effect of Complement and Viral Filtration on the Neutralization of Respiratory
More informationOverview of a neglected infectious disease: dengue
Overview of a neglected infectious disease: dengue Outline Current epidemiological trends Mechanisms underlying dengue transmission Dengue control Overview of recent modeling efforts Drivers of serotype
More informationDengue: The next vaccine preventable disease? Prof John McBride James Cook University
Dengue: The next vaccine preventable disease? Prof John McBride James Cook University Dengue viruses A flavivirus ~11kb genome, ~50nm diameter, lipid envelope. Gene order 5 C-prM-E-NS1 Four serotypes (1-4)
More informationDengue Virus IgM Elisa kit
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationLaboratory Testing for West Nile Virus Infections Testing Human & Non-Human Tissues
Laboratory Testing for West Nile Virus Infections Testing Human & Non-Human Tissues Robert S Lanciotti Chief; Diagnostic & Reference Laboratory Arbovirus Diseases Branch Fort Collins, Colorado Presentation
More informationWhat is the role of animal models in studying protective titres and the need for establishing surrogates/correlates of protection?
What is the role of animal models in studying protective titres and the need for establishing surrogates/correlates of protection? Alan D.T. Barrett Department of Pathology and Sealy Center for Vaccine
More informationWhat s Lurking out there??????
What s Lurking out there?????? Dave Warshauer, PhD, D(ABMM) Deputy Director, Communicable Diseases Wisconsin State Laboratory of Hygiene david.warshauer@slh.wisc.edu WISCONSIN STATE LABORATORY OF HYGIENE
More informationReport of Four Volunteers with Primary, Secondary and Tertiary Dengue Infections during a Prospective Cohort Study
Report of Four Volunteers with Primary, Secondary and Tertiary Dengue Infections during a Prospective Cohort Study Herman Kosasih a, Hadi Yusuf b, Primal Sudjana b, Bachti Alisjahbana b, Suharyono Wuryadi
More informationDengue in Jeddah, Saudi Arabia,
by Mazen Fakeeh and Ali M Zaki Virus Laboratory, Dr Solimon Fakeeh Hospital, Jeddah, Saudi Arabia Abstract Dengue virus (DEN-2) was first isolated from a fatal case of dengue haemorrhagic fever (DHF) in
More informationTest Report. Efficacy of A New JM Nanocomposite Material in Inhibiting Respiratory Syncytial Virus Cellular Infection
Test Report Efficacy of A New JM Nanocomposite Material in Inhibiting Respiratory Syncytial Virus Cellular Infection Test Reagent New JM Nanocomposite Material Project Commissioner JM Material Technology,
More informationSEROLOGIC EVIDENCE OF INFECTION OF WHITE-TAILED DEER IN TEXAS WITH THREE CALIFORNIA GROUP ARBOVIRUSES, (JAMESTOWN CANYON, SAN ANGELO, AND KEYSTONE)
SEROLOGIC EVIDENCE OF INFECTION OF WHITE-TAILED DEER IN TEXAS WITH THREE CALIFORNIA GROUP ARBOVIRUSES, (JAMESTOWN CANYON, SAN ANGELO, AND KEYSTONE) Authors: CHARLES J. ISSEL, GERALD L. HOFF, and DANIEL
More informationSynopsis of Findings from Recent Studies on Dengue in Sri Lanka
Synopsis of Findings from Recent Studies on Dengue in Sri Lanka S.A.M. Kularatne a*, S.L. Seneviratne b*, G.N. Malavige c*, S. Fernando c, V.G.N.S. Velathanthiri c, P.K. Ranatunga d, E.S. Wijewickrama
More informationMaria G. Gustav0 Jose Bravo,( ) Luis Valdes,(*) SusanaVazquez,( ) and Scott B. Halsteadt3)
Original Report Effect of age on outcome of secondary dengue 2 infections Maria G. Guzman,@) Gustav0 Kouri,@) Jose Bravo,( ) Luis Valdes,(*) SusanaVazquez,( ) and Scott B. Halsteadt3) Objective: Dengue
More informationReceived 13 January 2003/Returned for modification 17 March 2003/Accepted 1 April 2003
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, July 2003, p. 622 630 Vol. 10, No. 4 1071-412X/03/$08.00 0 DOI: 10.1128/CDLI.10.4.622 630.2003 Copyright 2003, American Society for Microbiology. All Rights
More informationState of the Art in the Prevention and Control of Dengue in the Americas May, 2014 Washington DC, USA
State of the Art in the Prevention and Control of Dengue in the Americas 28-29 May, 2014 Washington DC, USA Agenda Meeting on the State of the Art for the prevention and control of dengue in the Americas
More informationAssessing Seroprevalence of Dengue Fever in US Army Special Operations Forces
Assessing Seroprevalence of Dengue Fever in US Army Special Operations Forces LTC Jennifer Caci USASOC ESO GMCA 2009 Acknowledgements USASOC Surgeon s Office LTC Art Lyons, WRAIR MAJ Danielle Tack, 98
More informationDENGUE FEVER IN SOUTH AFRICA: AN IMPORTED DISEASE
DENGUE FEVER IN SOUTH AFRICA: AN IMPORTED DISEASE Veerle Msimang, Jacqueline Weyer, Chantel le Roux, Pat Leman, Alan Kemp, Janusz Paweska Centre for Emerging and Zoonotic Diseases, NICD Introduction Dengue
More informationJoseph E. Blaney, Jr.,* Jennifer M. Matro, Brian R. Murphy, and Stephen S. Whitehead
JOURNAL OF VIROLOGY, May 2005, p. 5516 5528 Vol. 79, No. 9 0022-538X/05/$08.00 0 doi:10.1128/jvi.79.9.5516 5528.2005 Recombinant, Live-Attenuated Tetravalent Dengue Virus Vaccine Formulations Induce a
More informationMaternal Antibody and Viral Factors in the Pathogenesis of Dengue Virus in Infants
MAJOR ARTICLE Maternal Antibody and Viral Factors in the Pathogenesis of Dengue Virus in Infants Cameron P. Simmons, 1 Tran Nguyen Bich Chau, 1 Tran Thi Thuy, 3 Nguyen Minh Tuan, 2 Dang Minh Hoang, 1 Nguyen
More informationDENGUE FEVER IN TRAVELLERS: AN INCREASING PROBLEM
Proc. R. Coll. Physicians Edinb. 1998; 28: 46-50 DENGUE FEVER IN TRAVELLERS: AN INCREASING PROBLEM S. A. Iwarson, * Department of Infectious Diseases, Sahlgreusha University Hospital, S-416 85 Göteborg,
More informationComparison between serological & molecular methods for diagnosis of dengue fever and its correlation with duration of illness
Original article Comparison between serological & molecular methods for diagnosis of dengue fever and its correlation with duration of illness Prashant Gangurde, Anjali Swami, Jayanthi Shastri Name of
More informationConditions Suitable for Vaccine Development
INFECTION AND IMMUNITY, Nov. 1976, p. 11-17 Copyright 1976 American Society for Microbiology Vol. 14, No. 5 Printed in U.S.A. Isolation of a Temperature-Sensitive Dengue- Virus Under Conditions Suitable
More informationSero-Prevalence of Dengue Infection by Rapid Immunochromatographic Assay from Tertiary Care Medical College Hospital in Coimbatore, India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 12 (2016) pp. 106-111 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.512.012
More informationSerological evidence of acute dengue virus infection among febrile patients attending Plateau State Specialist Hospital Jos, Nigeria
Serological evidence of acute dengue virus infection among febrile patients attending Plateau State Specialist Hospital Jos, Nigeria 1 Dawurung J.S, 2 Baba M.M, 3 Stephen G,, 3 Jonas S.C, 1 Bukbuk D. N.
More informationDENGUE AND BLOOD SAFETY. Ester C Sabino, MD, PhD Dep. of Infectious Disease/Institute of Tropical Medicine University of São Paulo
DENGUE AND BLOOD SAFETY Ester C Sabino, MD, PhD Dep. of Infectious Disease/Institute of Tropical Medicine University of São Paulo Dengue virus Arbovirus (arthropod-borne virus) virus transmitted by mosquitoes:
More informationImmunological enhancement and the pathogenesis of dengue haemorrhagic fever
J. Hyg., Camb. (1982), 89, 355-364 355 Printed in Great Britain Immunological enhancement and the pathogenesis of dengue haemorrhagic fever BY J. S. PORTERFIELD Sir William Dunn School of Pathology, South
More informationThe Effect of Environment on the Replication of Poliovirus in Monkey Kidney Cells
J. gen. Mimobiol. (1961), 25, 421428 Printed in Great Britain 421 The Effect of Environment on the Replication of Poliovirus in Monkey Kidney Cells BY G. FURNESS" Department of Microbiology, University
More informationBY F. BROWN, B. CARTWRIGHT AND DOREEN L. STEWART Research Institute (Animal Virus Diseases), Pirbright, Surrey. (Received 22 August 1962) SUMMARY
J. gen. Microbial. (1963), 31, 179186 Prinied in Great Britain 179 The Effect of Various Inactivating Agents on the Viral and Ribonucleic Acid Infectivities of FootandMouth Disease Virus and on its Attachment
More informationA Short History of Dengue and Mahidol Dengue
A Short History of Dengue and Mahidol Dengue Vaccine Sutee Yoksan Center for Vaccine Development, Institute of Molecular Biosciences, Mahidol University, Phutthamonthon, Nakhon Pathom, Thailand Abstract.
More informationIdentification of Microbes Lecture: 12
Diagnostic Microbiology Identification of Microbes Lecture: 12 Electron Microscopy 106 virus particles per ml required for visualization, 50,000-60,000 magnification normally used. Viruses may be detected
More information熱帯医学 Tropical medicine 39(3/4). p81
NAOSITE: Nagasaki University's Ac Title Author(s) Positive Case Detection of Anti-Den ELISA Using Monovalent and Tetraval Infected C6/36 Cell Culture Fluid Igarashi, Akira; Antonio, Maria Ter Citation
More informationDivision of Virology, National Institute for Medical Research, Mill Hill, London, NW7 IAA. (Accepted I3 December I973)
J. gen. ViroL (1974), 3, 91-96 Printed in Great Britain 9~ The Flaviviruses (Group B Arboviruses): a Cross-neutralization Study By A. T. DE MADRID AND J. S. PORTERFIELD Division of Virology, National Institute
More informationZika Virus Basics. Flaviviridae Flavivirus Disease Vector Vaccine *Dengue (serotypes 1-4) Zika Virus Basics. Zika Virus Transmission Cycle
Zika: Infection,, and Protection Roxanne P. Liles, Ph.D., MLS(ASCP) CM Assistant Professor of Biology Louisiana State University at Alexandria 318-473-6518 rliles@lsua.edu Zika Virus Basics Virion: Enveloped
More information